Table 4 Baseline clinical parameters of the investigated study cohort.
From: Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease
Indeterminate (n = 92) | Cardiac (n = 87) | Digestive (n = 21) | Cardiodigestive (n = 32) | Controls (n = 104) | |
|---|---|---|---|---|---|
Age [Range] | 57 [34–76] | 51 [34–90] | 57 [36–81] | 57 [37–73] | 51 [37–72] |
Sex (Male/Female) | 34/58 | 46/41 | 15/16 | 18/14 | 54/50 |
Ethnicity (Euro-Brazilian/Others) | 80/12 | 58/29 | 15/6 | 23/9 | 91/13 |
Cardiac impairment (A,B,C,D)* | NA | (27,22,36,02) | NA | (11,07,12,02) | NA |
Erythrocytes (RBCs) (Million cells/µL), [Range] | 4.7 [4.2–6.5] | 5.0 [3.6–6.0] | 4.8 [4.2–6.5] | 5.0 [4.3–5.6] | NA |
Hemoglobin (mg/dL), [Range] | 14.4 [10.9–45.7] | 14.8 [9.0–17.7] | 14.6 [13.2–17.3] | 14.9 [12.9–17.4] | NA |
uCRP levels (mg/dL), [Range] | 0.33 [0.08–3.77] | 0.34 [0.08–4.25] | 0.19 [0.09–0.38] | 0.34 [0.08–0.76] | NA |
CR1 levels (ng/mL), [Range] | 11.73 [6.16–51.61] | 10.72 [6.16–37.93] | 9.46 [6.74–53.17] | 9.64 [7.34–40.97] | 17.25 [6.69–67.35] |
LVEF (%), [Range] | 70 [35–84] | 65 [45–82] | NA | 66 [47–77] | NA |
